Together, our study demonstrates GNA13 may be served as a prognostic biomarker for HCC patients after curative hepatectomy, in which high expression of GNA13 suggests poor prognosis of HCC patients. The gene discussed is GNA13; the disease is hepatocellular carcinoma.